- Home
- ALLK vs GDL Comparison
ALLK vs GDL Comparison
Compare ALLK & GDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLK
- GDL
- Stock Information
- Founded
- ALLK 2012
- GDL 2006
- Country
- ALLK United States
- GDL United States
- Employees
- ALLK N/A
- GDL N/A
- Industry
- ALLK Biotechnology: Pharmaceutical Preparations
- GDL Investment Managers
- Sector
- ALLK Health Care
- GDL Finance
- Exchange
- ALLK Nasdaq
- GDL Nasdaq
- Market Cap
- ALLK 101.0M
- GDL 94.9M
- IPO Year
- ALLK 2018
- GDL N/A
- Fundamental
- Price
- ALLK $0.86
- GDL $8.15
- Analyst Decision
- ALLK Hold
- GDL
- Analyst Count
- ALLK 4
- GDL 0
- Target Price
- ALLK $1.67
- GDL N/A
- AVG Volume (30 Days)
- ALLK 827.7K
- GDL 11.2K
- Earning Date
- ALLK 03-13-2025
- GDL 01-01-0001
- Dividend Yield
- ALLK N/A
- GDL 6.02%
- EPS Growth
- ALLK N/A
- GDL N/A
- EPS
- ALLK N/A
- GDL N/A
- Revenue
- ALLK N/A
- GDL N/A
- Revenue This Year
- ALLK N/A
- GDL N/A
- Revenue Next Year
- ALLK N/A
- GDL N/A
- P/E Ratio
- ALLK N/A
- GDL N/A
- Revenue Growth
- ALLK N/A
- GDL N/A
- 52 Week Low
- ALLK $0.54
- GDL $7.65
- 52 Week High
- ALLK $1.69
- GDL $8.13
- Technical
- Relative Strength Index (RSI)
- ALLK 35.16
- GDL 59.30
- Support Level
- ALLK $0.81
- GDL $8.12
- Resistance Level
- ALLK $1.00
- GDL $8.17
- Average True Range (ATR)
- ALLK 0.13
- GDL 0.06
- MACD
- ALLK -0.03
- GDL 0.01
- Stochastic Oscillator
- ALLK 8.43
- GDL 89.47
About ALLK Allakos Inc.
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation.
About GDL GDL Fund The of Beneficial Interest
GDL Fund is a diversified closed-end management investment company. Its primary investment objective is to achieve absolute returns in various market conditions without excessive risk of capital. The fund seeks to achieve its objective by investing in merger arbitrage transactions and, to a lesser extent, in corporate reorganizations involving stubs, spin-offs, and liquidations.